Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor α

Molecular Endocrinology

Volumn 22, Issue 9, 2008, Pages 2085-2098

  Park, Se Hyung ^a   Cheung, Lydia W T ^b   Wong, Alice S T ^b   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

BASE SEQUENCE; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; OVARIAN NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UP-REGULATION;

GASTROPODA;

EID: 50649124650     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0512     Document Type: Article

References (78)

1. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255-288
2. Thiery JP 2002 Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454
3. Lee JM, Dedhar S, Kalluri R, Thompson EW 2006 The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973-981
4. Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-Pinilla SM, Villa S, Bolos V, Jorda M, Fabra A, Portillo F, Palacios J, Cano A 2006 Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66:9543-9556
5. Behrens J 2000 Control of β-catenin signaling in tumor development. Ann NY Acad Sci 910:21-33; discussion 33-25
6. Hu XC, Loo WT, Chow LW 2002 E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life Sci 71: 1397-1404
7. Mitselou A, Ioachim E, Peschos D, Charalabopoulos K, Michael M, Agnantis NJ, Vougiouklakis T 2007 E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Exp Oncol 29:54-60
8. Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y 2006 Frequent occurrence of abnormal E-cadherin/β-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis. Oncology 71:102-110
9. Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Berardi A, Garosi L, Suriano G, Vindigni C, De Stefano A, Leoncini L, Seruca R, Pinto E 2007 Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol 33:448-451
10. Hennig G, Lowrick O, Birchmeier W, Behrens J 1996 Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 271:595-602
11. Risinger JI, Berchuck A, Kohler MF, Boyd J 1994 Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7:98-102
12. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ 2000 E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569-573
13. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA 2000 The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76-83
14. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A 2003 The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116:499-511
15. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F 2001 The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7:1267-1278
16. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, Cano A 2001 A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 276:27424-27431
17. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939
18. Nieto MA 2002 The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3:155-166
19. Hajra KM, Chen DY, Fearon ER 2002 The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62:1613-1618
20. Jiao W, Miyazaki K, Kitajima Y 2002 Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86:98-101
21. Kurrey NK, K A, Bapat SA 2005 Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 97:155-165
22. Brekelmans CT 2003 Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 15:63-68
23. Runnebaum IB, Stickeler E 2001 Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127:73-79
24. Lau KM, Mok SC, Ho SM 1999 Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96: 5722-5727
25. Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC 2001 Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology 142:2351-2360
26. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV 2000 Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 36:657-666
27. Gambacciani M, Monteleone P, Sacco A, Genazzani AR 2003 Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract Res Clin Endocrinol Metab 17:139-147
28. Rao BR, Slotman BJ 1991 Endocrine factors in common epithelial ovarian cancer. Endocr Rev 12:14-26
29. Silva EG, Tornos C, Deavers M, Kaisman K, Gray K, Gershenson D 1998 Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation. Gynecol Oncol 71:240-246
30. Song J, Fadiel A, Edusa V, Chen Z, So J, Sakamoto H, Fishman DA, Naftolin F 2005 Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett 220:57-65
31. Greiser CM, Greiser EM, Doren M 2007 Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update 13: 453-463
32. Giacalone PL, Daures JP, Ouafik L, Martin PM, Laffargue F, Maudelonde T 2003 Steroids and adrenomedullin growth patterns in human ovarian cancer cells: estrogenic-regulation assay. Gynecol Oncol 91:651-656
33. Stopper H, Schmitt E, Gregor C, Mueller SO, Fischer WH 2003 Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells. Mutagenesis 18:243-247
34. Hirohashi S, Kanai Y 2003 Cell adhesion system and human cancer morphogenesis. Cancer Sci 94:575-581
35. Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS 1999 Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology 140:800-804
36. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251
37. Hua W, Christianson T, Rougeot C, Rochefort H, Clinton GM 1995 SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol 55: 279-289
38. Lacey JV, Jr., Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C 2002 Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334-341
39. Chien CH, Wang FF, Hamilton TC 1994 Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells. Mol Cell Endocrinol 99:11-19
40. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H 1998 Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 75:654-658
41. Voutilainen KA, Anttila MA, Sillanpaa SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM 2006 Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol 59:460-467
42. Darai E, Scoazec JY, Walker-Combrouze F, Mlika-Cabanne N, Feldmann G, Madelenat P, Potet F 1997 Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Hum Pathol 28:922-928
43. Yuecheng Y, Hongmei L, Xiaoyan X 2006 Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis 23:65-74
44. Maines-Bandiera SL, Auersperg N 1997 Increased Ecadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int J Gynecol Pathol 16:250-255
45. Veatch AL, Carson LF, Ramakrishnan S 1994 Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 58:393-399
46. Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T, Konishi I 2003 Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163:1437-1447
47. Rathi A, Virmani AK, Schorge JO, Elias KJ, Maruyama R, Minna JD, Mok SC, Girard L, Fishman DA, Gazdar AF 2002 Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clin Cancer Res 8:3324-3331
48. Ding JX, Feng YJ, Yao LQ, Yu M, Jin HY, Yin LH 2006 The reinforcement of invasion in epithelial ovarian cancer cells by 17 β-estradiol is associated with up-regulation of Snail. Gynecol Oncol 103:623-630
49. Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV 2003 Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res 63:5203-5208
50. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A 2000 The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84-89
51. Ikenouchi J, Matsuda M, Furuse M, Tsukita S 2003 Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 116: 1959-1967
52. Ohkubo T, Ozawa M 2004 The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117: 1675-1685
53. Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A 2005 Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 118:3371-3385
54. Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M, Hosokawa H, Nagayama M 2003 Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 22:891-898
55. Tripathi MK, Misra S, Chaudhuri G 2005 Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells. Biochem Biophys Res Commun 329:508-515
56. Elloul S, Silins I, Trope CG, Benshushan A, Davidson B, Reich R 2006 Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 449: 520-528
57. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
58. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580
59. Sabbah M, Courilleau D, Mester J, Redeuilh G 1999 Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96:11217-11222
60. Moggs JG, Murphy TC, Lim FL, Moore DJ, Stuckey R, Antrobus K, Kimber I, Orphanides G 2005 Anti-proliferative effect of estrogen in breast cancer cells that reexpress ERα is mediated by aberrant regulation of cell cycle genes. J Mol Endocrinol 34:535-551
61. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M 2006 A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20: 2513-2526
62. Rutherford T, Brown WD, Sapi E, Aschkenazi S, Munoz A, Mor G 2000 Absence of estrogen receptor-β expression in metastatic ovarian cancer. Obstet Gynecol 96:417-421
63. Chan KK, Wei N, Liu SS, Xiao-Yun L, Cheung AN, Ngan HY 2008 Estrogen receptor subtypes in ovarian cancer: a clinical correlation. Obstet Gynecol 111:144-151
64. Brandenberger AW, Tee MK, Jaffe RB 1998 Estrogen receptor α (ER-α) and β (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-β in neoplastic tissues. J Clin Endocrinol Metab 83:1025-1028
65. Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue F, Rochefort H, Maudelonde T 1998 Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 58:5367-5373
66. O'Donnell AJ, Macleod KG, Burns DJ, Smyth JF, Langdon SP 2005 Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr Relat Cancer 12: 851-866
67. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price Jr RH, Pestell RG, Kushner PJ 2002 Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 277:24353-24360
68. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F 2001 ER β inhibits proliferation and invasion of breast cancer cells. Endocrinology 142:4120-4130
69. Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, Giacalone PL, Chalbos D, Maudelonde T, Rochefort H, Pujol P 2002 Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21: 1097-1107
70. Treeck O, Pfeiler G, Mitter D, Lattrich C, Piendl G, Ortmann O 2007 Estrogen receptor β1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinol 193:421-433
71. Cheng J, Lee EJ, Madison LD, Lazennec G 2004 Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566:169-172
72. Filardo EJ, Quinn JA, Frackelton Jr AR, Bland KI 2002 Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84
73. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Ando S, Maggiolini M 2007 G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866
74. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2003 Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "ying yang" relationship between ERα and ERβ in mice. Mol Endocrinol 17:203-208
75. Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, Berens ME 1989 Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 63:280-288
76. Hayashida Y, Urata Y, Muroi E, Kono T, Miyata Y, Nomata K, Kanetake H, Kondo T, Ihara Y 2006 Calreticulin represses E-cadherin gene expression in Madin-Darby canine kidney cells via Slug. J Biol Chem 281:32469-32484
77. Ikuta T, Kawajiri K 2006 Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor. Exp Cell Res 312:3585-3594
78. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S, Baulida J, Franci C, Dedhar S, Larue L, Garcia de Herreros A 2004 Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23:7345-7354